SRD5A2: 3-oxo-5-alpha-steroid 4-dehydrogenase 2
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Catalyzes the irreversible stereospecific reduction of the delta 4,5 bond (double bond between carbons 4 and 5) of various 3-oxo steroids (3-keto steroids) producing their 5alpha dihydro-3-oxo forms.
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Finasteride | Approved | Steroid 5-alpha-reductase 2 inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
- 0.83
- Androgenetic alopecia
- 0.70
- Benign prostatic hyperplasia
- 0.63
- Prostate carcinoma
- 0.61
- Prostate cancer
- 0.57
- Prostate neoplasm
- 0.47
- Hypotrichosis
- 0.46
- Alopecia
- 0.45
- Hypogonadism
- 0.43
- Micropenis
- 0.42
- Neoplasm
- 0.39
- Skin aging
- 0.34
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- SRD5A2
- Related
- Steroid 5-alpha-reductase
Drugs and mechanisms are from ChEMBL CHEMBL1856 (CC BY-SA 3.0). Gene name, function (UniProt P31213, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets